Is clinical tolerance realistic in the next decade?

Transplant International

Volumn 19, Issue 7, 2006, Pages 539-548

  Ashton Chess, Joanna ^a   Brouard, Sophie ^a   Soulillou, Jean Paul ^a,b  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

Author keywords

Clinic; Kidney transplantation; Operational tolerance; Tolerance

Indexed keywords

15 DEOXYSPERGUALIN; ABATACEPT; ALEMTUZUMAB; B7 ANTIBODY; CD3 ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOSPORIN; CYCLOSPORIN A; IMMUNOTOXIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD28; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ALLOGRAFT; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; GRAFT FAILURE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY DISEASE; LYMPH NODE IRRADIATION; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; T CELL DEPLETION; THROMBOEMBOLISM;

ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; ISOANTIGENS; KIDNEY TRANSPLANTATION; TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 33745064578     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00339.x     Document Type: Review

References (80)

1. Hariharan S Johnson CP Bresnahan BA Taranto SE McIntosh MJ Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000 342 : 605.
2. Soulillou JP Giral M. Controlling the incidence of infection and malignancy by modifying immunosuppression. Transplantation 2001 72 ( 12 Suppl. S89.
3. London NJ Farmery SM Will EJ Davison AM Lodge JP. Risk of neoplasia in renal transplant patients. Lancet 1995 346 : 403.
4. Dantal J Hourmant M Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998 351 : 623.
5. Nankivell BJ Borrows RJ Fung CL O'Connell PJ Chapman JR Allen RD. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation 2004 78 : 557.
6. Pascual M Theruvath T Kawai T Tolkoff-Rubin N Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002 346 : 580.
7. Nankivell BJ Borrows RJ Fung CL O'Connell PJ Allen RD Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003 349 : 2326.
8. Erlich HA Opelz G Hansen J. HLA DNA typing and transplantation. Immunity 2001 14 : 347.
9. Billingham RE Brent L Medawar PB. Activity acquired tolerance of foreign cells. Nature 1953 172 : 603.
10. Roussey-Kesler G Giral M Moreau M, et al. Clinical operational tolerance after kidney transplantation. Am J Transplant 2006 6 : 736.
11. Calne R Friend P Moffatt S, et al. Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet 1998 351 : 1701.
12. Manilay JO Pearson DA Sergio JJ Swenson KG Sykes M. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation 1998 66 : 96.
13. Adams B Nagy N Paulart F Vanderhaeghen ML Goldman M Flamand V. CD8+ T lymphocytes regulating Th2 pathology escape neonatal tolerization. J Immunol 2003 171 : 5071.
14. Wells AD Li XC Strom TB Turka LA. The role of peripheral T-cell deletion in transplantation tolerance. Philos Trans R Soc Lond B Biol Sci 2001 356 : 617.
15. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990 248 : 1349.
16. Sebille F Vanhove B Soulillou JP. Mechanisms of tolerance induction: blockade of co-stimulation. Philos Trans R Soc Lond B Biol Sci 2001 356 : 649.
17. Lakkis FG Arakelov A Konieczny BT Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000 6 : 686.
18. Wood KJ Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003 3 : 199.
19. Koshiba T Kitade H Van Damme B, et al. Regulatory cell-mediated tolerance does not protect against chronic rejection. Transplantation 2003 76 : 588.
20. Pirenne J Kitade H Kawai M, et al. Regulatory cells, TH1/TH2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation 2005 79 ( 3 Suppl. S25.
21. Sayegh MH Fine NA Smith JL Rennke HG Milford EL Tilney NL. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 1991 114 : 954.
22. Sellers MT Deierhoi MH Curtis JJ, et al. Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up. Transplantation 2001 71 : 1681.
23. Strober S Modry DL Hoppe RT, et al. Induction of specific unresponsiveness to heart allografts in mongrel dogs treated with total lymphoid irradiation and antithymocyte globulin. J Immunol 1984 132 : 1013.
24. Strober S Dhillon M Schubert M, et al. Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med 1989 321 : 28.
25. Strober S Benike C Krishnaswamy S Engleman EG Grumet FC. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation 2000 69 : 1549.
26. Knechtle SJ Vargo D Fechner J, et al. FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts. Transplantation 1997 63 : 1.
27. Armstrong N Buckley P Oberley T, et al. Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. Transplantation 1998 66 : 5.
28. Thomas JM Contreras JL Jiang XL, et al. Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin. Transplantation 1999 68 : 1660.
29. Thomas JM Eckhoff DE Contreras JL, et al. Durable donor-specific T and B cell tolerance in rhesus macaques induced with peritransplantation anti-CD3 immunotoxin and deoxyspergualin: absence of chronic allograft nephropathy. Transplantation 2000 69 : 2497.
30. Chiffoleau E Beriou G Dutartre P Usal C Soulillou JP Cuturi MC. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment. J Immunol 2002 168 : 5058.
31. Kirk AD Hale DA Mannon RB, et al. Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation 2003 76 : 120.
32. Kirk AD Mannon RB Kleiner DE, et al. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation 2005 80 : 1051.
33. Bloom DD Hu H Fechner JH Knechtle SJ. T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation 2006 81 : 81.
34. Bauer TM Jiga LP Chuang JJ Randazzo M Opelz G Terness P. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl Int 2005 18 : 95.
35. Kirk AD Harlan DM Armstrong NN, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997 94 : 8789.
36. Kirk AD Tadaki DK Celniker A, et al. Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. Transplantation 2001 72 : 377.
37. Boulday G Ashton-Chess J Bernard P, et al. Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons. Nephrol Dial Transplant 2004 19 : 1752.
38. Vincenti F Larsen C Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005 353 : 770.
39. Vanhove B Laflamme G Coulon F, et al. Selective blockade of CD28 and not CTLA-4 with a single-chain Fv-alpha1-antitrypsin fusion antibody. Blood 2003 102 : 564.
40. Haspot F Seveno C Dugast AS, et al. Anti-CD28 antibody-induced kidney allograft tolerance related to tryptophan degradation and TCR class II B7 regulatory cells. Am J Transplant 2005 5 : 2339.
41. Kenyon NS Chatzipetrou M Masetti M, et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci USA 1999 96 : 8132.
42. Kirk AD Burkly LC Batty DS, et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999 5 : 686.
43. Soulillou JP Blandin F Gunther E Lemoine V. Genetics of the blood transfusion effect on heart allografts in rats. Transplantation 1984 38 : 63.
44. Bugeon L Cuturi MC Hallet MM Paineau J Chabannes D Soulillou JP. Peripheral tolerance of an allograft in adult rats - characterization by low interleukin-2 and interferon-gamma mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 1992 54 : 219.
45. Opelz G Vanrenterghem Y Kirste G, et al. Prospective evaluation of pretransplant blood transfusions in cadaver kidney recipients. Transplantation 1997 63 : 964.
46. Alexander JW Light JA Donaldson LA, et al. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Transplantation 1999 68 : 1117.
47. Bashuda H Kimikawa M Seino K, et al. Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates. J Clin Invest 2005 115 : 1896.
48. Louis S Braudeau C Giral M, et al. Contrasting CD25hiCD4+T Cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006 81 : 398.
49. Wekerle T Sykes M. Mixed chimerism and transplantation tolerance. Annu Rev Med 2001 52 : 353.
50. Kawai T Cosimi AB Colvin RB, et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation 1995 59 : 256.
51. Thomas JM Carver FM Foil MB, et al. Renal allograft tolerance induced with ATG and donor bone marrow in outbred rhesus monkeys. Transplantation 1983 36 : 104.
52. Kawai T Cosimi AB Wee SL, et al. Effect of mixed hematopoietic chimerism on cardiac allograft survival in cynomolgus monkeys. Transplantation 2002 73 : 1757.
53. Jacobsen N Taaning E Ladefoged J Kristensen JK Pedersen FK. Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor. Lancet 1994 343 : 800.
54. Helg C Chapuis B Bolle JF, et al. Renal transplantation without immunosuppression in a host with tolerance induced by allogeneic bone marrow transplantation. Transplantation 1994 58 : 1420.
55. Butcher JA Hariharan S Adams MB Johnson CP Roza AM Cohen EP. Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression. Clin Transplant 1999 13 : 330.
56. Barber WH Mankin JA Laskow DA, et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991 51 : 70.
57. Millan MT Shizuru JA Hoffmann P, et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 2002 73 : 1386.
58. Spitzer TR Delmonico F Tolkoff-Rubin N, et al. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999 68 : 480.
59. Buhler LH Spitzer TR Sykes M, et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 2002 74 : 1405.
60. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003 3 : 51.
61. Kamada N Brons G Davies HS. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation 1980 29 : 429.
62. Qian S Demetris AJ Murase N Rao AS Fung JJ Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994 19 : 916.
63. Calne RY Sells RA Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969 223 : 472.
64. Devlin J Doherty D Thomson L, et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 1998 27 : 926.
65. Takatsuki M Uemoto S Inomata Y, et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001 72 : 449.
66. Zoller KM Cho SI Cohen JJ Harrington JT. Cessation of immunosuppressive therapy after successful transplantation: a national survey. Kidney Int 1980 18 : 110.
67. Uehling DT Hussey JL Weinstein AB Wank R Bach FH. Cessation of immunosuppression after renal transplantation. Surgery 1976 79 : 278.
68. Cai J Lee J Jankowska-Gan E, et al. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 2004 199 : 1017.
69. Burlingham WJ Grailer AP Fechner Jr. JH, et al. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 1995 59 : 1147.
70. Christensen LL Grunnet N Rudiger N Moller B Birkeland SA. Indications of immunological tolerance in kidney transplantation. Tissue Antigens 1998 51 : 637.
71. Pescovitz MD Thistlethwaite JR Jr. Auchincloss H Jr., et al. Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med 1984 160 : 1495.
72. Baeten D Louis S Braud C, et al. Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. J Am Soc Nephrol 2006 17 : 294.
73. Brouard S Dupont A Giral M, et al. Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am J Transplant 2005 5 : 330.
74. Adams AB Williams MA Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003 111 : 1887.
75. Knechtle SJ Burlingham WJ. Metastable tolerance in nonhuman primates and humans. Transplantation 2004 77 : 936.
76. Torrealba JR Katayama M Fechner Jr. JH, et al. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol 2004 172 : 5753.
77. Mazariegos GV Zahorchak AF Reyes J Chapman H Zeevi A Thomson AW. Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant 2005 5 : 314.
78. VanBuskirk AM Burlingham WJ Jankowska-Gan E, et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000 106 : 145.
79. Kirk AD. Ethics in the quest for transplant tolerance. Transplantation 2004 77 : 947.
80. Ojo A Wolfe RA Agodoa LY, et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation 1998 66 : 1651.